Skip to Content

CD22, FLOWCYTOMETRY (SDL10806)

https://www.scanlabglobal.com/web/image/product.template/4363/image_1920?unique=18393fc
This test detects CD22 expression to confirm B-cell lineage in ALL or lymphoma. Positive results guide inotuzumab therapy, targeting CD22-positive cells in B-cell malignancies.

300.00 AED 300.0 AED 300.00 AED

300.00 AED

Not Available For Sale

This combination does not exist.